A carregar...
Longitudinal effect of disease-modifying therapy on tricuspid regurgitant velocity in children with sickle cell anemia
Elevated tricuspid regurgitant velocity (TRV) ≥2.5 m/s is a predictor of disease severity in adults and children with sickle cell anemia (SCA), but how disease-modifying therapies (DMTs) affect this biomarker is incompletely understood. We investigated the effect of DMTs on TRV elevation in children...
Na minha lista:
| Publicado no: | Blood Adv |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society of Hematology
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7805333/ https://ncbi.nlm.nih.gov/pubmed/33570630 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020003197 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|